Literature DB >> 12404566

Caffeine (4 mg/kg) influences sustained attention and delayed free recall but not memory predictions.

William L. Kelemen1, Catherine E. Creeley.   

Abstract

This experiment was conducted to examine the influence of a moderate dose of caffeine (4 mg/kg) on delayed memory, metamemory, and sustained attention. One hundred and forty-two volunteers ingested either caffeine or placebo during a study session which included three different memory tasks (free recall, cued recall, and recognition), and they made predictions of future memory performance. On day 2, participants again ingested either caffeine or placebo and completed memory tests. Sustained attention performance was measured on both days, and caffeine reliably improved hit rates and response latencies. A reliable drug-state interaction was detected only in the free recall test of memory. Caffeine did not affect the magnitude or accuracy of memory predictions, but there was some evidence that expectancies about caffeine were related to cognitive performance. Overall, caffeine's impact on memory and metamemory was not robust in this study. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Year:  2001        PMID: 12404566     DOI: 10.1002/hup.287

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  3 in total

Review 1.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

2.  Cognitive Impairment in Patients with Chronic Neuropathic or Radicular Pain: An Interaction of Pain and Age.

Authors:  Orla Moriarty; Nancy Ruane; David O'Gorman; Chris H Maharaj; Caroline Mitchell; Kiran M Sarma; David P Finn; Brian E McGuire
Journal:  Front Behav Neurosci       Date:  2017-06-13       Impact factor: 3.558

3.  Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesion.

Authors:  Guy Sandner; Marie-Josée Angst; Thierry Guiberteau; Blandine Guignard; Astrid Nehlig
Journal:  Front Behav Neurosci       Date:  2014-01-28       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.